Lawmakers’ explosive charges turn a global spotlight on China’s WuXi, and it’s feeling the heat

It doesn’t take a lot to disrupt a relationship between a biopharma company and a global CRO/CDMO. From the smallest startup shepherding a single drug into the clinic to a major pharma player looking for substantial outside help in R&D and manufacturing, these contractual alliances run for years, with enormous…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks